1. Home
  2. CCCC vs BHR Comparison

CCCC vs BHR Comparison

Compare CCCC & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.05

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

BHR

Braemar Hotels & Resorts Inc.

HOLD

Current Price

$2.76

Market Cap

199.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
BHR
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
185.1M
199.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CCCC
BHR
Price
$3.05
$2.76
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.2M
357.9K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
7.02%
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$1.09
$1.80
52 Week High
$3.64
$3.19

Technical Indicators

Market Signals
Indicator
CCCC
BHR
Relative Strength Index (RSI) 69.53 40.55
Support Level $1.96 $2.58
Resistance Level $3.07 $2.96
Average True Range (ATR) 0.29 0.11
MACD 0.09 -0.03
Stochastic Oscillator 87.76 12.77

Price Performance

Historical Comparison
CCCC
BHR

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

Share on Social Networks: